Long-term results of a randomized phase 3 trial comparing idarubicin and daunorubicin in younger patients with acute myeloid leukaemia-Reference-Cited by-同舟云学术

Long-term results of a randomized phase 3 trial comparing idarubicin and daunorubicin in younger patients with acute myeloid leukaemia

Published:2013-10-09 Issue:2 Volume:28 Page:440-443
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Récher C, ,Béné M C,Lioure B,Pigneux A,Vey N,Delaunay J,Luquet I,Hunault M,Guyotat D,Bouscary D,Fegueux N,Jourdan E,Lissandre S,Escoffre-Barbe M,Bonmati C,Randriamalala E,Guièze R,Ojeda-Uribe M,Dreyfus F,Harousseau J L,Cahn J Y,Ifrah N,Guardiola P

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2013290.pdf

Reference15 articles.

1. Rowe JM . Optimal induction and post-remission therapy for AML in first remission. Hematology Am Soc Hematol Educ Program 2009, 396–405.

2. Lowenberg B, Pabst T, Vellenga E, van Putten W, Schouten HC, Graux C et al. Cytarabine dose for acute myeloid leukemia. N Engl J Med 2011; 364: 1027–1036.

3. Fernandez HF, Sun Z, Yao X, Litzow MR, Luger SM, Paietta EM et al. Anthracycline dose intensification in acute myeloid leukemia. N Engl J Med 2009; 361: 1249–1259.

4. Chevallier P, Fornecker L, Lioure B, Bene MC, Pigneux A, Recher C et al. Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial. Leukemia 2010; 24: 1380–1385.

5. Lioure B, Bene MC, Pigneux A, Huynh A, Chevallier P, Fegueux N et al. Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS study. Blood 2012; 119: 2943–2948.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy and safety of eleven induction chemotherapy regimens for young adult patients with newly diagnosed acute myeloid leukemia: a network meta-analysis;Annals of Hematology;2022-04-20

2. New Tricks and Old Dogs: Will the Addition of Venetoclax to Conventional Multidrug Chemotherapy Decrease Relapse Risk for Younger Adults With Newly Diagnosed AML?;The Hematologist;2022

3. What Is the Best Choice and Dose of Anthracycline for Induction Chemotherapy in Acute Myeloid Leukemia?;Acute Leukemias;2021-03-24

4. Combination of cyclophosphamide and cytarabine as induction regimen for newly diagnosed adult acute myeloid leukemia;eJHaem;2020-07

5. Outcome of patients aged 60‐75 years with newly diagnosed secondary acute myeloid leukemia: A single‐institution experience;Cancer Medicine;2019-06-07